Infection and Immunity, May 2000, p. 2573-2578, Vol. 68, No. 5
0019-9567/00/$04.00+0

TB Research Group, Veterinary Laboratories Agency, Addlestone, Surrey KT15 3NB, United Kingdom1; AgResearch, Wallaceville Animal Research Centre, Upper Hutt, New Zealand2; and GBF, D38124 Braunschweig, Germany3
Received 12 October 1999/Returned for modification 15 February 2000/Accepted 22 February 2000
| |
ABSTRACT |
|---|
|
|
|---|
This report describes the kinetics of T-cell responses to a panel of mycobacterial antigens (PPD-M, PPD-A, ESAT-6, Ag85, 38kD, MPB64, MPB70, MPB83, hsp16.1, hsp65, and hsp70) following experimental infection of cattle with Mycobacterium bovis. Increased antigen-specific lymphocyte proliferation, gamma interferon, and interleukin-2 responses were observed in all calves following infection. Positive lymphocyte proliferation and cytokine responses to PPD-M and ESAT-6 were observed throughout the infection period studied. In contrast, responses to all other antigens were more variable and were not constantly present, suggesting that antigen cocktails rather than individual antigens should be used for immunodiagnosis. The detection of cytokine responses in the absence of lymphocyte proliferation, particularly during the early stages of infection, suggests a role for antigen-specific cytokine readout systems in the early identification of M. bovis infection in cattle.
| |
INTRODUCTION |
|---|
|
|
|---|
The control of bovine tuberculosis in Great Britain currently relies upon a test-and-slaughter strategy in which animals infected with Mycobacterium bovis are identified using the single comparative intradermal tuberculin skin test (23). However, the incidence of bovine tuberculosis is increasing in the British national herd and the urgent need for new and improved cattle vaccines and diagnostic aids has been clearly stated in a recent independent scientific review (10). For the rational development of such reagents, it is important to assess the nature of the early immune responses that occur in cattle following infection with M. bovis.
An experimental low-dose M. bovis challenge system for
cattle has been previously described which results in the development of lesions that are distributed similarly to those seen in naturally occurring bovine tuberculosis (2). This model has been used to show that following infection of cattle with M. bovis,
tuberculin-induced lymphocyte proliferation, gamma interferon
(IFN-
), and interleukin-2 (IL-2) responses are generated (3,
19). An intranasal-challenge model has also been used to describe
the mobilization of peripheral T cells following infection with
M. bovis (20), the presence of ESAT-6-driven
IFN-
responses (21), and also lymphocyte proliferation and IFN-
responses to MPB64 and MPB70 (15) in both
experimentally and naturally infected cattle.
Great variation in the cellular response, both between individuals and
over time within an individual, to mycobacterial antigens purified from
M. bovis culture filtrate by gel electrophoresis has been
previously described in cattle infected with M. bovis (8). Such variation has important ramifications for the
evaluation of potential diagnostic reagents. We therefore set out to
delineate the kinetics of T-cell (proliferation, IFN-
, and IL-2)
responses to a panel of defined mycobacterial antigens in cattle
experimentally infected intratracheally with an isolate of M. bovis from Great Britain. The antigens chosen for this study were
selected on the basis of their ability to induce cellular immune
responses in bovine or human tuberculosis (1, 8, 14-16, 21,
25-26, 31-33, 36). Antigens included were the bovine (PPD-M)
and avian (PPD-A) tuberculin preparations routinely used in the
diagnosis of bovine tuberculosis, a group of proteins that are either
secreted by live mycobacteria or associated with the cell wall (MPB64,
MPB70, MPB83, ESAT-6, Ag85, and 38kD), and three somatic stress
proteins (hsp16.1, hsp65, and hsp70).
This report describes the kinetics of cellular recognition of these individual antigens by cattle experimentally infected with M. bovis from the time of infection until gross tuberculous lesions were well developed. Results generated by this report show how antigens may be differentially recognized over the time course of infection and reinforce the need for cocktails, rather than single antigens, in diagnostic tests. Our results also support the use of rapid and sensitive cytokine readout systems as a potential method for the early diagnosis of bovine tuberculosis.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Mycobacterial antigens.
The mycobacterial antigens used in
this study are described in Table 1.
Bovine (PPD-M) and avian (PPD-A) tuberculin preparations and the
recombinant proteins ESAT-6, MPB70, and MPB83 were produced at the
Veterinary Laboratories Agency (VLA), Weybridge, United Kingdom, as
described previously (32). Recombinant MPB64 was kindly
provided by D. Bakker (Animal Health Science, Boxtel, The Netherlands).
Native Ag85, isolated from M. bovis BCG culture filtrate as
described previously (34) and comprising Ag85A, -B and -C,
was donated by K. Huygen (Instituut Pasteur, Brussels, Belgium).
Recombinant hsp16.1, hsp65, and hsp70 and 38kD lipoprotein were a kind
gift from M. Singh (GBF, Braunschweig, Germany).
|
Experimental animals. Four female Friesian Limousin cross calves (CN1100, CN1104, CN1098, and CN1109) approximately 6 months of age were obtained from a herd free of bovine tuberculosis (i.e., with a history of negative skin test results). The calves were inoculated intratracheally in accordance with the protocol described by Buddle et al. (4) with M. bovis (AF2122/97). Two calves (CN1104 and CN1100) received 6.6 × 104 CFU, and two calves (CN1098 and CN1109) received 6.6 × 105 CFU. During the study, animals were housed in a high-security isolation unit under negative pressure and expelled air was filtered. Two weeks prior to postmortem, all animals were tested by the single comparative intradermal tuberculin skin test using avian and bovine tuberculin as stated by the European Economic Community directive (7).
Postmortem examinations and culture for M. bovis. Euthanasia was carried out at 19 or 20 weeks postinfection by intravenous injection of sodium pentobarbitone, and a detailed postmortem was performed. Each of the following lymph nodes (or lymph node chains) was removed aseptically: right and left lateral retropharyngeal, right and left medial retropharyngeal, right and left submandibular, right and left cervical superficial, right and left bronchial, cranial mediastinal chain, caudal mediastinal chain, and representative samples of the mesenteric chain. These lymph nodes were subsequently serially sliced (approximately 2 mm) with a scalpel and inspected. Samples from individual nodes and lesions were obtained for mycobacterial culture and histological examination. The remaining superficial and visceral lymph nodes were inspected in situ. Each lung lobe was serially sliced (approximately 5 mm), and all slices were palpated and inspected. The respiratory airways were cut open as far into the lung parenchyma as possible and inspected.
Lymphocyte proliferation assay.
Peripheral blood mononuclear
cells (PBMC) were separated from heparinized venous blood over
Histopaque 1077 (Sigma) and resuspended in culture medium (RPMI 1640 medium with Glutamax [Gibco] supplemented with 5% CPSR [serum
replacement; Gibco], nonessential amino acids [Gibco], penicillin at
100 U/ml, streptomycin at 100 µg/ml, and 5 × 10
5
M 2-mercaptoethanol [Gibco]). Cells were resuspended to 2 × 106/ml, and 0.1 ml was added per well to 96-well
flat-bottom microtiter plates (Nunc). Antigens were added at 0.1 ml/well in triplicate (10-µg/ml final concentration of all antigens
used in this study). The cultures were incubated for 5 days at 37°C
in 5% CO2, pulsed with tritiated thymidine (37 kBq/well;
Amersham, Amersham, United Kingdom), and harvested 24 h later.
Incorporated radioactivity was determined as counts per minute by
-scintillation counting. Results are expressed as the change in
counts per minute (mean counts per minute in the presence of antigen
minus mean counts per minute in the absence of antigen) for each
antigen at each time point for each animal. A positive result was taken
as a mean counts per minute value of cultures stimulated with antigen
that was greater than three times the mean counts per minute of
unstimulated cultures and also greater than 2,000.
IFN-
ELISA.
Duplicate cultures of peripheral whole blood
diluted 1:1 in culture medium (120 µl of blood-120 µl of medium
per well in 96-well flat-bottom microtiter trays) were incubated in the
presence or absence of antigen (10 µg/ml) for 24 h by the method
described by Emery et al. (6). Neat supernatants harvested
from these cultures were assessed for IFN-
content using a
commercially available antigen capture enzyme-linked immunosorbent
assay (ELISA) kit (BOVIGAM; CSL Ltd., Parkville, Victoria, Australia)
and following the manufacturer's instructions. The results are
expressed as the change in optical density at 450 nm
(
OD450 [mean OD450 in the presence of
antigen minus mean OD450 in the absence of antigen]) for
each antigen at each time point for each animal. A positive response
was taken as a mean OD450 of antigen-stimulated cell supernatants that was greater than twice the mean OD450 of
unstimulated cell supernatants and also greater than 0.2.
IL-2 bioassay.
IL-2 in neat peripheral blood (1:1 with
antigen as for the IFN-
ELISA described above) 24-h culture
supernatants was measured by determining the ability of each
supernatant to maintain the proliferation of lymphoblasts generated by
stimulation with concanavalin A (ConA) by the method of Emery et al.
(6). Peripheral blood culture supernatants (50 µl) were
added to the ConA blasts (104/well) in duplicate. The
plates were incubated for 24 h at 37°C in 5% CO2,
pulsed with tritiated thymidine, and harvested 24 h later. The
specificity of this bioassay for IL-2 has been previously determined by
inhibition with a monoclonal antibody specific for the alpha subunit of
the IL-2 receptor CD25 (11, 18). The results are expressed
as the proliferation (change in counts per minute) of IL-2-dependent
ConA blast cells (i.e., the mean counts per minute of cells in the
presence of antigen-stimulated supernatant minus the mean counts per
minute of cells in the presence of unstimulated control supernatant). A
positive result was taken as a mean counts per minute value of ConA
blasts in the presence of antigen-stimulated supernatants that was
greater than three times the mean counts per minute of blasts in the
presence of unstimulated supernatants and also greater than 2,000.
| |
RESULTS |
|---|
|
|
|---|
Pathological findings. Gross tuberculous lesions were observed in all four infected animals, i.e., in the lateral and medial retropharyngeal, right submandibular, and bronchial lymph nodes of CN1109; in the medial retropharyngeal, bronchial, and mediastinal lymph nodes and also in the larynx, trachea, and lungs of CN1098; in the lateral and medial retropharyngeal, submandibular, bronchial, and mediastinal lymph nodes and in the nasal mucosa, trachea, bronchi, and lungs of CN1104; and in the lateral retropharyngeal, bronchial, mediastinal, and mesenteric lymph nodes and in the lungs of CN1100. The lesions were histopathologically confirmed as tuberculous granulomas, and M. bovis was cultured from these lesions.
Antigen-specific PBMC proliferation.
The kinetics of
antigen-specific PBMC proliferation in all four animals (CN1104,
CN1100, CN1098, and CN1109) is shown in Fig. 1. There were no obvious differences in
the proliferative responses of these four animals that could be
attributed to the dose of M. bovis received. While there
were obvious differences between individual animals in their responses
to the antigens, there were also similarities. First, all developed an
increased response to PPD-M relative to PPD-A by 6 weeks postinfection.
This M. bovis-specific response was the strongest
proliferative response observed (maximum, approximately 60,000 to
130,000 cpm) and was maintained in all of the animals at higher levels
relative to the avian tuberculin throughout the infection period.
Second, responses to ESAT-6 developed as rapidly in two of the four
animals and were, after PPD-M, the strongest responses to any of the
other antigens in our panel (maximum, 20,000 to 50,000 cpm). A response
to Ag85 was observed at only one time point (12 weeks postinfection),
while positive responses to MPB64, MPB70, and MPB83 were observed at
two or three time points (peaks of activity at 6 to 7, 12 to 14, and 20 weeks postinfection). Responses to these antigens were relatively weak compared to responses to ESAT-6 (approximate maxima: Ag85, 10,000 to
20,000 cpm; MPB64, 10,000 to 16,000 cpm; MPB70, 7,000 to 21,000 cpm;
MPB83, 2,500 to 35,000 cpm).
|
Antigen-specific cytokine production. (i) IFN-
.
Figure
2 shows the antigen-specific IFN-
responses of all four animals (CN1104, CN1100, CN1098, and CN1109).
IFN-
responses to bovine tuberculin were detected between 2 and 7 weeks after infection with M. bovis. Similar to
proliferation, the IFN-
response to PPD-M was thereafter maintained
above that of the response to PPD-A. An IFN-
response to ESAT-6 was
observed in all of the animals almost concurrently with the IFN-
response to PPD-M, and the strengths of these responses were very
similar (maximum OD450: PPD-M, 2.4 to 3.1; ESAT-6, 1.8 to
3.1). IFN-
responses were also observed in the absence of and before
the onset of proliferation. This was particularly noticeable in animal
CN1109, in which proliferative responses were relatively low or absent
before 12 weeks postinfection, yet strong IFN-
responses to all of
the antigens tested were observed during this period, from as early as
4 weeks postinfection. Similarly, IFN-
responses were observed in
the absence of proliferation in CN1100 to Ag85 and hsp70; in CN1104 to
Ag85, MPB70, and MPB83; and in CN1098 to Ag85 and MPB70.
|
(ii) IL-2.
Figure 3 shows the
antigen-specific IL-2 responses of all four animals (CN1104, CN1100,
CN1098, and CN1109). PPD-M, PPD-A, and ESAT-6 elicited positive IL-2
responses between 2 and 6 weeks postinfection. These antigens, together
with Ag85, induced the strongest IL-2 responses observed (maximum,
9,000 to 20,000 cpm). The IL-2 responses to all of the other antigens
tested were relatively low (most were less than 5,000 cpm). Similar to
the IFN-
responses described above, IL-2 responses were also
observed in the absence of and before the onset of proliferation, e.g.,
in CN1109 to Ag85, MPB64, MPB70, and hsp65; in CN1098 to Ag85 and
MPB83; in CN1104 to Ag85, MPB83, and MPB70; and in CN1100 to Ag85 and
MPB64.
|
| |
DISCUSSION |
|---|
|
|
|---|
This report describes the specificities of T-cell responses in
cattle experimentally infected with M. bovis and follows the kinetics of these responses from infection to the development of
tuberculous lesions. Antigen-specific T-cell proliferation and IFN-
and IL-2 responses to a panel of mycobacterial antigens were assessed
at regular intervals throughout the infection period.
All four calves responded in broadly similar manners in that positive responses generated to bovine tuberculin and ESAT-6 were largely sustained throughout the infection period, while responses to all of the other antigens tested displayed marked periodicity within each individual animal, and positive responses to these latter antigens were not always detectable. These results are in full agreement with those of Fifis et al. (8), who showed that the cellular response of M. bovis-infected cattle to individual antigens not only varied between animals but also changed over the time course of infection. Whether this periodic nature of antigen recognition in cattle is related to the turnover of mycobacterial growth in vivo (data suggest intervals of 5 to 7 weeks between peaks of cellular activity) or due to the sequestration of reactive clones, as suggested for human tuberculosis (27), or some other form of suppression is unknown. Presumably, clones reactive to immunodominant antigens such as ESAT-6 may be present in the circulation at a higher frequency and therefore would not be so noticeably affected by sequestration.
Our experimental bovine tuberculosis data confirm ESAT-6 as a good candidate antigen for diagnosis (22). However, a recent study of naturally infected field reactors showed that ESAT-6 elicited positive proliferative responses in just 67% of the animals tested (32). Therefore, cocktails of different antigens, rather than reliance upon a single antigen, are required for confidence in the diagnosis of large numbers of cattle from diverse genetic backgrounds. This is further illustrated by the use of protein (5) and peptide (32) cocktails of several mycobacterial antigens, including ESAT-6, MPB64, MPB70, and MPB83, to differentiate between BCG-vaccinated and M. bovis-infected cattle. The use of cocktails also avoids the possibility of selecting for deletion mutants of M. bovis, i.e., those lacking that particular diagnostic antigen, such as described for strains of M. tuberculosis which do not express the 19-kDa lipoprotein (12).
In our study, proliferation generally coincided with cytokine (IFN-
and IL-2) production; however, there were some noticeable discrepancies. For example, modest proliferation responses to Ag85 were
observed only at week 12 whereas this antigen appeared to be a strong
stimulus for the production of both IFN-
and IL-2 at a number of
time points both before and after week 12. Similarly, we observed
cytokine responses to a number of other antigens, including hsp65,
hsp70, MPB64, MPB70, and MPB83, both in the absence of proliferation
and, in some cases, before the onset of proliferative responses
following infection. In particular, one animal (CN1100) that had a very
limited antigen-specific proliferation response (tuberculin and ESAT-6
only) nevertheless showed positive cytokine responses to other antigens
(e.g., IFN-
and IL-2 responses to Ag85 and IL-2 response to MPB64).
These results all support the measurement of antigen-specific cytokine
responses as a method of early, sensitive detection of infection. How
cytokine responses compare with detection by the tuberculin skin test
is not known. However, the fact that cytokine tests may detect infected
animals as early as 2 to 3 weeks after infection, together with the
convenience of a single farm visit and test result availability within
48 h, has obvious attractions. We are aware that the final
measurements in this study, of T-cell proliferation and cytokine
production, were made 2 weeks after the tuberculin skin test, which may
have had some boosting effect upon the cellular responses. This was
most noticeable in our study in the PBMC proliferative responses of two
of the four (high-dose) animals. The boosting effect of skin testing upon PPD-specific IFN-
production in whole-blood cultures from M. bovis-infected cattle has been previously documented
(28). However, while we believe that skin testing may have
contributed to the responses seen immediately prior to necropsy,
boosting of all responses was not apparent at this time point in all of the animals, and therefore, measurements taken at this time point may
also constitute part of the natural fluctuations observed in
individual-antigen recognition.
In summary, this report describes in detail the lymphocyte
proliferation, IFN-
, and IL-2 responses of M. bovis-infected cattle to a panel of defined mycobacterial
antigens, from infection to the development of tuberculous lesions.
This study confirms that ESAT-6 is a dominant antigen during the early
stages of M. bovis infection in cattle. However, our results
support the rationale for using cocktails of antigens for diagnostic
assays, rather than relying on individual antigens in order to counter
the variability observed in antigen recognition throughout the
infection process. This study also confirms that the detection of
antigen-specific cytokine production would be a useful tool for the
early diagnosis and identification of M. bovis-infected cattle.
| |
ACKNOWLEDGMENTS |
|---|
We thank veterinary surgeons Derek Clifford and Neil Palmer (VLA) and also Mark Chambers and Paul Cockle (VLA) for carrying out the infection and postmortem procedures. Thanks also go to K. Huygen (Instituut Pasteur, Brussels, Belgium) and D. Bakker (Animal Health Science, Boxtel, The Netherlands) for supplying the antigens Ag85 and MPB64, respectively.
This work was funded by the Ministry of Agriculture, Fisheries and Food, United Kingdom.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: VLA, Addlestone, Surrey KT15 3NB, United Kingdom. Phone: 01932-341111. Fax: 01932-357684. E-mail: srhodes.vla{at}gtnet.gov.uk.
Present address: Division of Wildlife, SVA, Uppsala, Sweden.
Editor: S. H. E. Kaufmann
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Boom, W. H.,
R. S. Wallis, and K. A. Chervenak.
1991.
Human Mycobacterium tuberculosis-reactive CD4+ T cell clones: heterogeneity in antigen recognition, cytokine production and cytotoxicity for mononuclear phagocytes.
Infect. Immun.
59:2737-2743 |
| 2. | Buddle, B. M., F. E. Aldwell, A. Pfeffer, G. W. de Lisle, and L. A. Corner. 1994. Experimental Mycobacterium bovis infection of cattle: effect of dose of M. bovis and pregnancy on immune responses and distribution of lesions. N. Z. Vet. J. 42:167-172. |
| 3. | Buddle, B. M., G. W. de Lisle, A. Pfeffer, and F. E. Aldwell. 1995. Immunological responses and protection against Mycobacterium bovis in calves vaccinated with a low dose of BCG. Vaccine 13:1123-1130[CrossRef][Medline]. |
| 4. | Buddle, B. M., D. Keen, A. Thomson, G. Jowett, J. Heslop, G. W. deLisle, and J. L. Stanford. 1995. Protection of cattle from bovine tuberculosis by vaccination with BCG by the respiratory or subcutaneous route, but not by vaccination with killed Mycobacterium vaccae. Res. Vet. Sci. 59:10-16[CrossRef][Medline]. |
| 5. |
Buddle, B. M.,
N. A. Parlane,
D. L. Keen,
F. E. Aldwell,
J. M. Pollock,
K. Lightbody, and P. Andersen.
1999.
Differentiation between Mycobacterium bovis BCG-vaccinated and M. bovis-infected cattle by using recombinant mycobacterial antigens.
Clin. Lab. Diagn. Immunol.
6:1-5 |
| 6. | Emery, D. L., F. H. Duffy, and P. R. Wood. 1988. An analysis of cellular proliferation and synthesis of lymphokines and specific antibody in vitro by leucocytes from immunized cattle. Vet. Immunol. Immunopathol. 18:67-80[CrossRef][Medline]. |
| 7. | European Economic Community. 1980. EEC directive 80/219 EEC, ammending directive 64/432 annexe B. Off. J. L047:25-32. |
| 8. | Fifis, T., L. A. Corner, J. S. Rothel, and P. R. Wood. 1994. Cellular and humoral immune responses of cattle to purified Mycobacterium bovis antigens. Scand. J. Immunol. 39:267-274[CrossRef][Medline]. |
| 9. | Hewinson, R. G., S. L. Michell, W. P. Russell, R. A. McAdam, and W. R. Jacobs, Jr. 1996. Molecular characterization of MPT83: a seroreactive antigen of Mycobacterium tuberculosis with homology to MPT70. Scand. J. Immunol. 43:490-499[CrossRef][Medline]. |
| 10. | Krebs, J. R., R. M. Anderson, T. Clutton-Brock, W. I. Morrison, D. Young, and C. Donnely. 1997. Bovine tuberculosis in cattle and badgers. Report to the Rt. Hon. Dr. Jack Cunningham M.P. MAFF Publications, London, United Kingdom. |
| 11. |
Kuhnle, G.,
R. A. Collins,
J. E. Scott, and G. M. Keil.
1996.
Bovine interleukins 2 and 4 expressed in recombinant bovine herpesvirus 1 are biologically active secreted glycoproteins.
J. Gen. Virol.
77:2231-2240 |
| 12. | Lathigra, R., Y. Zhang, M. Hill, M. J. Garcia, P. S. Jackett, and J. Ivanyi. 1996. Lack of production of the 19-kDa glycolipoprotein in certain strains of Mycobacterium tuberculosis. Res. Microbiol. 147:237-249[Medline]. |
| 13. |
Li, H.,
J. C. Ulstrup,
T. O. Jonassen,
K. Melby,
S. Nagai, and M. Harboe.
1993.
Evidence for the absence of the MBP64 gene in some substrains of Mycobacterium bovis BCG.
Infect. Immun.
61:1730-1734 |
| 14. | Lightbody, K. A., R. M. Girvin, D. A. Pollock, D. P. Mackie, S. D. Neill, and J. M. Pollock. 1998. Recognition of a common mycobacterial T cell epitope in MPB59 of Mycobacterium bovis. Immunology 93:314-322[CrossRef][Medline]. |
| 15. | Lightbody, K. A., R. M. Girvin, D. P. Mackie, S. D. Neil, and J. M. Pollock. 1998. T-cell recognition of mycobacterial proteins MPB70 and MPB64 in cattle immunised with antigen and infected with Mycobacterium bovis. Scand. J. Immunol. 48:44-51[CrossRef][Medline]. |
| 16. |
Lyashchenko, K. P.,
J. M. Pollock,
R. Colangeli, and M. L. Gennaro.
1998.
Diversity of antigen recognition by serum antibodies in experimental bovine tuberculosis.
Infect. Immun.
66:5344-5349 |
| 17. |
Muira, K.,
S. Nagai,
M. Kinomoto,
S. Haga, and T. Tokunaga.
1983.
Comparative studies with various substrains of Mycobacterium bovis BCG on the production of an antigenic protein.
Infect. Immun.
39:540-545 |
| 18. | Naessens, G., M. Selighem, N. MacHugh, Y. H. Park, W. C. Davis, and P. Toye. 1992. Selection of BoCD25 monoclonal antibodies by screening mouse L cells transfected with the bovine P55-interleukin 2 (IL-2) receptor gene. Immunology 76:305-309[Medline]. |
| 19. |
Ng, K. H.,
F. E. Aldwell,
N. Wedlock,
J. D. Watson, and B. M. Buddle.
1997.
Antigen-induced interferon- and interleukin-2 responses of cattle inoculated with Mycobacterium bovis.
Vet. Immunol. Immunopathol.
57:59-68[CrossRef][Medline].
|
| 20. | Pollock, J. M., D. A. Pollock, D. G. Campbell, R. M. Girvin, and A. D. Crockard. 1996. Dynamic changes in circulating and antigen-responsive T-cell sub-populations post-Mycobacterium bovis infection in cattle. Immunology 87:236-241[CrossRef][Medline]. |
| 21. | Pollock, J. M., and P. Andersen. 1997. Predominant recognition of the ESAT-6 protein in the first phase of infection with Mycobacterium bovis in cattle. Infect. Immun. 65:2587-2592[Abstract]. |
| 22. | Pollock, J. M., and P. Andersen. 1997. The potential of the ESAT-6 antigen secreted by virulent mycobacteria for specific diagnosis of tuberculosis. J. Infect. Dis. 175:1251-1254[Medline]. |
| 23. | Pritchard, D. G. 1988. A century of bovine tuberculosis 1888-1988: conquest and controversy. J. Comp. Pathol. 15:651-663. |
| 24. | Radford, A. J., P. R. Wood, H. Billman-Jacobe, H. M. Geysen, T. J. Mason, and G. Tribbick. 1990. Epitope mapping of the Mycobacterium bovis secretory protein MPB70 using overlapping peptide analysis. J. Gen. Microbiol. 136:265-272[Medline]. |
| 25. |
Roche, P. W.,
P. W. Peake,
H. Billman-Jocobe,
T. Doran, and W. J. Britton.
1994.
T-cell determinants and antibody binding sites on the major mycobacterial secretory protein MPB59 of Mycobacterium bovis.
Infect. Immun.
62:5319-5326 |
| 26. | Roche, P. W., C. G. Feng, and W. J. Britton. 1996. Human T cell epitopes on the Mycobacterium tuberculosis secreted protein MPT64. Scand. J. Immunol. 43:662-670[CrossRef][Medline]. |
| 27. | Rook, G. A., J. W. Carswell, and J. L. Stanford. 1976. Preliminary evidence for the trapping of antigen-specific lymphocytes in the lymphoid tissue of "anergic" tuberculosis patients. Clin. Exp. Immunol. 26:129-132[Medline]. |
| 28. | Rothel, J. S., S. L. Jones, L. A. Corner, J. C. Cox, and P. R. Wood. 1992. The gamma-interferon assay for diagnosis of bovine tuberculosis in cattle: conditions affecting the production of gamma-interferon in whole blood culture. Aust. Vet. J. 69:1-4[Medline]. |
| 29. | Sørensen, A. L., S. Nagai, G. Houen, P. Andersen, and Å. B. Andersen. 1995. Purification and characterization of a low-molecular-mass T-cell antigen secreted by Mycobacterium tuberculosis. Infect. Immun. 63:1710-1717[Abstract]. |
| 30. |
Verbon, A.,
R. A. Hartskeerl,
A. Schuitema,
A. H. J. Kolk,
D. B. Young, and R. Lathigra.
1992.
The 14,000-molecular-weight antigen of Mycobacterium tuberculosis is related to the alpha-crystallin family of low-molecular-weight heat shock proteins.
J. Bacteriol.
174:1352-1359 |
| 31. | Vordermeier, H. M., D. P. Harris, G. Frisca, E. Roman, H.-M. Surcel, C. Moreno, G. Pasvol, and J. Ivanyi. 1992. T cell repertoire in tuberculosis: selective anergy to an immunodominant epitope of the 38kDa antigen in patients with active disease. Eur. J. Immunol. 22:2631-2637[Medline]. |
| 32. |
Vordermeier, H. M.,
P. C. Cockle,
A. O. Whelan,
S. Rhodes,
N. Palmer,
D. Bakker, and R. G. Hewinson.
1999.
Development of diagnostic reagents to differentiate between Mycobacterium bovis BCG vaccination and M. bovis infection in cattle.
Clin. Diagn. Lab. Immunol.
6:675-682 |
| 33. |
Wiker, H. G.,
K. P. Lyashchenko,
A. M. Aksoy,
K. A. Lightbody,
J. M. Pollock,
S. V. Komissarenko,
S. O. Bobrovnik,
I. N. Kolesnikova,
L. O. Mykhalsky,
M. L. Gennaro, and M. Harboe.
1998.
Immunochemical characterisation of the MPB70/80 and MPB83 proteins of Mycobacterium bovis.
Infect. Immun.
66:1445-1452 |
| 34. |
Wiker, H. G.,
K. Sletten,
S. Nagai, and M. Harboe.
1990.
Evidence for three separate genes encoding the proteins of the mycobacterial antigen 85 complex.
Infect. Immun.
58:272-274 |
| 35. | Wiker, H. G., S. Nagai, R. G. Hewinson, W. P. Russell, and M. Harboe. 1996. Heterogenous expression of the related MPB70 and MPB83 proteins distinguish various substrains of Mycobacterium bovis BCG and Mycobacterium tuberculosis H37Rv. Scand. J. Immunol. 43:374-380[CrossRef][Medline]. |
| 36. | Wood, P. R., L. A. Corner, J. S. Rothel, J. L. Ripper, T. Fifis, B. S. McCormic, B. Francis, L. Melville, K. Small, K. DeWhittle, J. Tolston, T. J. Ryan, G. W. deLisle, J. C. Cox, and S. L. Jones. 1992. A field evaluation of serological and cellular diagnostic tests for bovine tuberculosis. Vet. Microbiol. 31:71-79[CrossRef][Medline]. |
| 37. |
Young, D.,
L. Kent,
A. Rees,
J. Lamb, and J. Ivanyi.
1986.
Immunological activity of a 38-kilodalton protein purified from Mycobacterium tuberculosis.
Infect. Immun.
54:177-183 |
| 38. |
Young, D.,
R. Lathigra,
R. Hendrix,
D. Sweetser, and R. A. Young.
1988.
Stress proteins are immune targets in leprosy and tuberculosis.
Proc. Natl. Acad. Sci. USA
85:4267-4270 |
| 39. |
Young, R. A.,
B. R. Bloom,
C. M. Grossinsky,
J. Ivanyi,
D. Thomas, and R. W. Davis.
1985.
Dissection of Mycobacterium tuberculosis antigens using recombinant DNA.
Proc. Natl. Acad. Sci. USA
82:2583-2587 |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|